New Treatment for Muscular Dystrophy, Developed at Atrium Health, Receives Global Recognition
Through research being conducted within the McColl-Lockwood Laboratory for Muscular Dystrophy Research at Atrium Health, there may soon be a treatment for patients with limb-girdle muscular dystrophy type 2I (LGMD2I).